Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,966 | -9,903 | -24,251 | -16,561 | -10,173 |
| Depreciation Amortization | 300 | 135 | 419 | 303 | 188 |
| Accounts payable and accrued liabilities | 180 | -401 | 2,224 | 568 | 1,165 |
| Other Working Capital | -2,909 | -2,075 | 3,241 | 2,843 | 1,733 |
| Other Operating Activity | 2,405 | 1,411 | -371 | 539 | -606 |
| Operating Cash Flow | $-20,990 | $-10,833 | $-18,738 | $-12,308 | $-7,693 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -941 | -188 | -1,019 | -938 | -772 |
| Purchase Of Investment | -106,566 | -86,626 | -97,810 | -36,039 | -32,343 |
| Sale Of Investment | 42,619 | 16,819 | 22,490 | 12,990 | 5,530 |
| Investing Cash Flow | $-64,888 | $-69,995 | $-76,339 | $-23,987 | $-27,585 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18 | N/A | 100 | 218 | 219 |
| Other Financing Activity | 79,166 | 79,559 | 122,840 | 124,038 | 124,793 |
| Financing Cash Flow | $79,184 | $79,559 | $122,940 | $124,256 | $125,012 |
| Beginning Cash Position | 47,964 | 47,964 | 20,101 | 20,101 | 20,101 |
| End Cash Position | 41,270 | 46,695 | 47,964 | 108,062 | 109,835 |
| Net Cash Flow | $-6,694 | $-1,269 | $27,863 | $87,961 | $89,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,990 | -10,833 | -18,738 | -12,308 | -7,693 |
| Capital Expenditure | -941 | -188 | -1,019 | -938 | -772 |
| Free Cash Flow | -21,931 | -11,021 | -19,757 | -13,246 | -8,465 |